| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
4,594.25
|
|
Change (%)
|
-99.20 (-2.11%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
4,580.75
-
4,710.85
|
|
52-Week Range (RS)
|
3,742.90
-
5,987.65
|
|
Beta (1 Year)
|
0.35
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Pfizer to declare Quarterly Results |
| Pfizer announces change in senior management |
| Pfizer signs supply and marketing agreement with Cipla |
| Pfizer standalone net profit rises 19.37% in the September 2025 quarter |
| Pfizer gains after Q2 PAT rises 19% YoY |
| Pfizer schedules board meeting |
| Pfizer Ltd - Pfizer Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018 : |
| Pfizer Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
| Volumes spurt at Star Health & Allied Insurance Company Ltd counter |
| Volumes jump at Pfizer Ltd counter |
|
|
|
| Incoporation Year : 1950 |
| Chairman : Pradip P Shah |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Pfizer Ltd
The Capital 1802/1901 Plot-C70,
G Bl Bandra Kurla Cpx Bandra-E,
Mumbai,
Maharashtra-400051 |
Phone:91-22-66932000
Fax:91-22-26540274 |
| E-Mail : contactus.india@pfizer.com |
| URL : http://www.pfizerindia.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
30-Jan-2026 |
4553.00 |
0.91 |
| 1Month |
06-Jan-2026 |
4908.75 |
-6.41 |
| 3Month |
06-Nov-2025 |
5073.20 |
-9.44 |
| 6Month |
06-Aug-2025 |
5052.80 |
-9.08 |
| 1Year |
06-Feb-2025 |
4416.05 |
4.04 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.84 |
550.42 |
| Quant Small Cap Fund |
1.52 |
417.35 |
| ICICI Pru Smallcap Fund |
2.13 |
179.56 |
| ICICI Pru Value Fund |
0.28 |
173.07 |
| Nippon India Multi Cap Fund |
0.34 |
163.68 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
27,373.40 |
0.51 |
35,921.55 |
26,560.05 |
58,168.48 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,485.85 |
1.75 |
3,515.95 |
1,968.00 |
42,111.80 |
| Astrazeneca Pharma India Ltd |
8,581.55 |
-0.48 |
10,653.05 |
6,501.60 |
21,453.88 |
| Sanofi Consumer Healthcare India Ltd |
4,259.10 |
-1.56 |
5,954.00 |
3,967.00 |
9,808.97 |
| Sanofi India Ltd |
4,001.90 |
-0.22 |
6,717.50 |
3,976.40 |
9,216.38 |
|
|
|
|